—— 要投稿,上万维,轻松学术交流

严正声明

本站非期刊官网,非中介代理,
不向作者收取任何费用!
举报微信:13140028228 冯老师

态度公正、信息求实、投稿自助、使用免费
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY《国际神经精神药理学杂志》
月刊 - 英国
  • INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY《国际神经精神药理学杂志》
  • SCIE外文期刊
  • 期发文量5
  • 国人占比31.25%
  • 投稿方式--官网投稿
  • 期刊属性

  • 中科分区:2区
    OA期刊:
  • 综述期刊:
    TOP期刊:
  • 期均国文:2
    环比增速:-66.67%
  • 期刊信息

  • 研究方向:医学-CLINICAL NEUROLOGY 临床神经病学;NEUROSCIENCES 神经科学;PHARMACOLOGY PHARMACY 药学;PSYCHIATRY 精神病学
  • 国际刊号:ISSN1461-1457;EISSN1469-5111
  • 期刊语言:英语
    出版地区:英国
  • 投稿网址:http://mc.manuscriptcentral.com/intjnp
  • 电子邮箱:
  • 期刊官网:https://academic.oup.com/ijnp
  • 作者指南:
  • 出版商网址:http://www.oxfordjournals.org
  • 出版地址:CAMBRIDGE UNIV PRESS, 32 AVENUE OF THE AMERICAS, NEW YORK, USA, NY, 10013-2473
  • 期刊简介:INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY《国际神经精神药理学杂志》(月刊). The central focus of the journal is on research that advances understanding of existing and new neuropsychopharmacological agents including their mode of action and clinical application or provides insights into the biological basis of psychiatric disorders and thereby advances their pharmacological treatment. Such research may derive from the full spectrum of biological and psychological fields of inquiry encompassing classical and novel techniques in neuropsychopharmacology as well as strategies such as neuroimaging, genetics, psychoneuroendocrinology and neuropsychology.

  • 万维提示


  • 1、投稿方式:在线投稿

    2期刊网址:https://academic.oup.com/ijnp

    3投稿网址:http://mc.manuscriptcentral.com/intjnp

    4、官网邮箱:graceaa@pitt.edu(主编)

    更多编辑邮箱如下。

    5、官网电话:

    (412) 624 4609(主编)(210) 567-4205(总编)

    6期刊刊期:月刊,一年出版12

    2021年8月13日星期

                                     

     

    期刊编辑邮箱、电话【官网信息】

     

    Field Editors

    Clinical Neuropsychopharmacology

    Michael Thase

    Email: thase@mail.med.upenn.edu

     

    Preclinical Neuropsychopharmacology

    Carla Gambarana

    Email: carla.gambarana@unisi.it

     

    David Morilak

    Email: morilak@uthscsa.edu

     

    Neuroimaging

    Gitte Moos Knudsen

    Email: gitte@nru.dk

     

    Molecular Genetics and Therapeutics

    David Goldman

    Email: davidgoldman@mail.nih.gov

     

    Managing Editor

    Ann Miller

    Telephone: (210) 567-4205

    Email: millera5@uthscsa.edu

     

    投稿须知【官网信息】

     

    Instructions to authors

    Please note that this journal is now fully open access and encourages authors to complete their license to publish online. For more information about Open Access licenses and charges, see the “Open Access” section for more information.

    The International Journal of Neuropsychopharmacology (IJNP) is the official scientific journal of the Collegium Internationale Neuro-psychopharmacologicum (CINP). IJNP aims to serve as a major forum for the rapid publication and wide dissemination of high quality, influential research in neuropsychopharmacology, in the basic and clinical domains. The central focus of IJNP is on research that (i) advances understanding of existing and new neuropsychopharmacological agents including their mode of action and clinical application, or (ii) provides insights into the biological basis of neuropsychiatric disorders and thereby advances their treatment, pharmacological, stimulation techniques, behavioral. Such research may derive from the full spectrum of biological and psychological fields of inquiry encompassing classical and novel techniques in neuropsychopharmacology as well as strategies such as neuroimaging, genetics, psychoneuroendocrinology, and neuropsychology. Priority is given to original research that is of wide interest and clearly advances the field.

    Editorial policies

    iThenticate

    IJNP uses iThenticate, a plagiarism detection software, to identify manuscripts that contain significant overlap with existing manuscripts already in publication. We are of course aware that oftentimes in Methods sections there is considerable overlap with previously published manuscripts.

    Authorship Disclosure Form

    All individuals included as authors of papers must have contributed substantially to the scientific process leading up to the writing of the paper. Such contribution includes the conception and design of the project, the performance of experiments and the analysis and interpretation of data. In addition the author should have made a substantial contribution to drafting or critical revision of the manuscript for important intellectual content.

    Please note that the Journal now requires that an Authorship Disclosure Form is completed by every author of the manuscript. It is the responsibility of the submitting author to collect the completed forms from all authors and to upload the forms in PDF format via ScholarOne. Papers with missing or incomplete forms will be returned to the author. Therefore, before you start submitting your paper please make sure that you have obtained all the completed forms.

    We are aware that authors sometimes receive assistance from technical writers, language editors, and/or writing agencies in preparing manuscripts for publication. Such assistance must be noted in the cover letter and in the Acknowledgements section along with a declaration that the author(s) are entirely responsible for the scientific content of the paper.

    Failure to acknowledge assistance from technical writers, language editors, and/or writing agencies in preparing manuscripts for publication in the cover letter and in the Acknowledgements section may lead to disqualification of the paper.

    Under no circumstances will IJNP accept submissions by writing or editorial agencies on behalf of authors and there will be no correspondence with writing or editorial agencies regarding submitted or revised manuscripts.

    ……

    更多详情:

    https://academic.oup.com/ijnp/pages/General_Instructions






欢迎点评!让信息更透明,使投稿更轻松!
  • 审稿时间:
    是否录用:
  • 见刊周期:
    查重要求:
  • 有无课题:
    有无回复:
  • 我的学历:
    我的职称:
  • 审稿费用:
    版面费用:
  • 稿       费:
    稿件字数:
  • 投稿难度:
  • 该刊可发:
  • 投稿主题:
匿名: 验证码: 点击切换验证码
    评分:0

    验证码: 点击切换验证码